Abstract
Drug manufacture now typically accounts for 25% of company revenues and
achieving agility in the manufacturing process has become essential for pharma
companies hoping to align their supply chains with constant shifts in global
product demand. In addition to offering efficiencies in cost, capacity and
time-to-market, contract manufacturing organizations (CMOs) can provide
innovative, state-of-the-art process and production technologies to support
the rapid technical transfer of products from R&D to commercial manufacturing.
However, the effective management of the CMO/sponsor relationship is critical
not only in satisfying regulatory requirements amid growing concerns over
quality control, but also in meeting the overall commercial aim of the
project. ' Contract Manufacturing Strategies' is a new report published by
Business Insights that explores the future of the contract manufacturing
market with a detailed analysis of emerging drivers and restraints, business
models and production strategies. The potential benefits and risks of contract
manufacturing are assessed and the key strategies for effective CMO selection
and successful relationship management are identified. This report also
reviews the latest FDA contract legislation to determine the most effective
measures in ensuring regulatory compliance and assesses the rapidly expanding
markets of India and China in terms of growth potential and regulatory
outlook. Understand how the CMO market will develop over the 2008-13 period,
identify emerging manufacturing strategies and regulatory developments and
assess the outsourcing growth potential of India and China...
View Cart
